DGX. Focus Diagnostics and 3M Launch FDA-Cleared Simplexa™ Test on 3M™ Cycler for Molecular Influenza and Respiratory Virus Testing by Moderate Complexity Healthcare Facilities
First moderate-complexity Simplexa™ assay developed through funding by U.S. Department of Health and Human Services' BARDA BAA program for public health preparedness
http://finance.yahoo.com/news/focus-diagnostics-3m-launch-fda-162700013.html
First moderate-complexity Simplexa™ assay developed through funding by U.S. Department of Health and Human Services' BARDA BAA program for public health preparedness
http://finance.yahoo.com/news/focus-diagnostics-3m-launch-fda-162700013.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
